Clinical Trial Update: A Study of Doxycycline and Tauroursodeoxycholic Acid (Doxy/TUDCA) Plus Standard Supportive Therapy Versus Standard Supportive Therapy Alone in Cardiac Amyloidosis Caused by Transthyretin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing doxycycline plus tauroursodeoxycholic acid (Doxy/TUDCA) with standard supportive therapy versus standard therapy alone in transthyreti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Cardiac Amyloidosis

Drugs mentioned

• Doxycycline (Doxycycline)
• Tauroursodeoxycholic acid (tauroursodeoxycholic acid)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: TTR Cardiac Amyloidosis | Phase 3 | Status: COMPLETED